Skip to main content
. 2024 Mar 19;16(6):1204. doi: 10.3390/cancers16061204

Figure 1.

Figure 1

Salivary duct carcinoma with HER-2 and androgen receptor. (A) Salivary duct carcinoma, hematoxylin and eosin (H&E) stain, 20×; (B) androgen receptor, 20×; (C) HER-2 negative (0+), 20×; (D) salivary duct carcinoma, H&E, 10×; (E) androgen receptor, 20×; (F) HER-2 positive (3+), 20×.